4‐month moxifloxacin containing regimens in the treatment of patients with sputum‐positive pulmonary tuberculosis in South India – a randomised clinical trial - Concepedia

Concepedia

Publication | Open Access

4‐month moxifloxacin containing regimens in the treatment of patients with sputum‐positive pulmonary tuberculosis in South India – a randomised clinical trial

DOI Full Paper Access

16

Citations

19

References

2020

Year

Banurekha Velayutham, M S Jawahar, Dina Nair, Pooranagangadevi Navaneethapandian, Ponnuraja Chinnaiyan, Kandasamy Chandrasekaran, Gomathi Narayan Sivaramakrishnan, Marimuthu Makesh Kumar, Paramasivam Paul Kumaran, S. Ramesh Kumar,

Tropical Medicine & International Health

Abstract

The 4-month daily moxifloxacin regimen [M4] was found to be equivalent and as safe as the 6-month thrice-weekly control regimen.

References

	Year	Citations

Page 1